These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 16735185

  • 1. Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
    Ito M, Ogino H, Oshima H, Shiraki N, Shibamoto Y, Kasai H, Mase M, Kawamura Y, Miyati T.
    Magn Reson Imaging; 2006 Jun; 24(5):625-30. PubMed ID: 16735185
    [Abstract] [Full Text] [Related]

  • 2. A comparative evaluation of CH3-DTPA-Gd (NMS60) for contrast-enhanced magnetic resonance angiography.
    Bammer R, de Crespigny AJ, Howard D, Seri S, Hashiguchi Y, Nakatani A, Moseley ME.
    Magn Reson Imaging; 2004 Jun; 22(5):619-24. PubMed ID: 15172054
    [Abstract] [Full Text] [Related]

  • 3. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [Abstract] [Full Text] [Related]

  • 4. An MRA study of vascular stenosis in a pig model using CH3-DTPA-Gd (NMS60) and Gd-DTPA.
    D'Arceuil HE, de Crespigny AJ, Pelc L, Howard D, Alley M, Seri S, Hashiguchi Y, Nakatani A, Moseley ME.
    Magn Reson Imaging; 2004 Nov; 22(9):1243-8. PubMed ID: 15607095
    [Abstract] [Full Text] [Related]

  • 5. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H, Enmi J, Teramoto N, Hayashi T, Yamamoto A, Tsuji T, Naito H, Iida H.
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [Abstract] [Full Text] [Related]

  • 7. Dynamic susceptibility contrast perfusion imaging of cerebral ischemia in nonhuman primates: comparison of Gd-DTPA and NMS60.
    Liu Y, D'Arceuil H, He J, Duggan M, Seri S, Hashiguchi Y, Nakatani A, Gonzalez RG, Pryor J, de Crespigny A.
    J Magn Reson Imaging; 2005 Oct; 22(4):461-6. PubMed ID: 16142700
    [Abstract] [Full Text] [Related]

  • 8. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU, Reiser MF, Huber AM.
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM, Ouyang H, Zhou CW.
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [Abstract] [Full Text] [Related]

  • 10. [Gd-DTPA in the diagnosis of brain metastasis].
    Kornienko VN, Pronin IN.
    Vestn Rentgenol Radiol; 1994 Feb; (5):5-10. PubMed ID: 7785209
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS, Jaw TS, Liu GC, Wang YM, Chen SH, Kuo YT, Jao JC, Li CW, Tsai KB.
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [Abstract] [Full Text] [Related]

  • 12. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A.
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [Abstract] [Full Text] [Related]

  • 13. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL, Mehndiratta A, Risse F, Rius M, Zechmann CM, von Tengg-Kobligk H, Gerigk L, Kauczor HU, Politi M, Essig M, Griffiths PD, Wilkinson ID.
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial.
    Hammerstingl R, Adam G, Ayuso JR, Van Beers B, Belfiore G, Bellin MF, Bongartz G, Ernst O, Frericks B, Giuseppetti G, Heinz-Peer G, Laghi A, Martin J, Pering C, Reimer P, Richter GM, Roemer FW, Schäfer FK, Vilgrain V, Vogl TJ, Weishaupt D, Wall A, Zech CJ, Tombach B.
    Invest Radiol; 2009 Mar; 44(3):168-76. PubMed ID: 19169143
    [Abstract] [Full Text] [Related]

  • 15. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F, Fraioli F, Catalano C, Napoli A, Danti M, Francone M, Venditti F, Nardis P, Passariello R.
    Radiol Med; 2003 Mar; 106(1-2):87-93. PubMed ID: 12951555
    [Abstract] [Full Text] [Related]

  • 16. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304
    [Abstract] [Full Text] [Related]

  • 17. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN, Pronin IN, Turkin AM, Fadeeva LM.
    Zh Vopr Neirokhir Im N N Burdenko; 1993 Mar 13; (4):13-7. PubMed ID: 8296501
    [Abstract] [Full Text] [Related]

  • 18. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 13; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 19. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
    Yrjänä SK, Vaara T, Karttunen A, Koivukangas J.
    Invest Radiol; 2008 Apr 13; 43(4):267-75. PubMed ID: 18340251
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.